The prognostic value of squamous differentiation in endometrioid type endometrial cancer: a matched analysis

References

• Abeler VM, Kjørstad KE. 1992. Endometrial adenocarcinoma with squamous cell differentiation. Cancer 69:488–495.
   PubMed Web of Science ®Google Scholar
• Black D, Soslow RA, Levine DA, Tornos C, Chen SC, Hummer AJ, et al. 2006. Clinicopathologic significance of defective DNA mismatch repair in endometrial carcinoma. Journal of Clinical Oncology 24:1745–1753.
   PubMed Web of Science ®Google Scholar
• Creasman W. 2009. Revised FIGO staging for carcinoma of the endometrium. International Journal of Gynecology & Obstetrics 105:109.
   PubMed Web of Science ®Google Scholar
• Creasman W, Morrow C, Bundy B, Homesley H, Graham J, Heller P. 1987. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 60:2035–2041.
   PubMed Web of Science ®Google Scholar
• Creasman WT, Odicino F, Maisonneuve P, Quinn MA, Beller U, Benedet JL, et al. 2006. Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. International Journal of Gynecology & Obstetrics 95:105–143.
   PubMed Web of Science ®Google Scholar
• Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Wárlám-Rodenhuis CC, et al. 2000. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. The Lancet 355:1404–1411.
   PubMed Web of Science ®Google Scholar
• Colombo N, Creutzberg C, Amant F, Bosse T, González-Martín A, Ledermann J, et al. 2016. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up. International Journal of Gynecologic Cancer 26:2–30.
   PubMed Web of Science ®Google Scholar
• De Andrade DAP, Da Silva VD, De Macedo Matsushita G, De Lima MA, De Andrade Vieira M, Andrade CEMC, et al. 2019. Squamous differentiation portends poor prognosis in low and intermediate-risk endometrioid endometrial cancer. PLoS ONE 14:e0220086.
   PubMed Web of Science ®Google Scholar
• Engelsen IB, Stefansson I, Akslen LA, Salvesen HB. 2006. Pathologic expression of p53 or p16 in preoperative curettage specimens identifies high-risk endometrial carcinomas. American Journal of Obstetrics and Gynecology 195:979–986.
   PubMed Web of Science ®Google Scholar
• Ikawa S, Sano T, Furumoto H, Aono T. 1999. Multidirectional differentiation of endometrial carcinoma with special reference to tumor aggressiveness evaluated by Ki-67 expression. Gynecologic Oncology 72:323–330.
   PubMed Web of Science ®Google Scholar
• Jiang W, Chen J, Tao X, Huang F, Zhu M, Wang C, Feng W. 2017. Possible risk factors of pulmonary metastases in patients with international federation of gynecology and obstetrics stage i endometrioid-type endometrial cancer. International Journal of Gynecologic Cancer 27:1206–1215.
   PubMedGoogle Scholar
• Keys HM, Roberts JA, Brunetto VL, Zaino RJ, Spirtos NM, Bloss JD, et al. 2004. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecologic Oncology 92:744–751.
   PubMed Web of Science ®Google Scholar
• Kurman RJ, Carcangiu ML, Herrington CS. 2014. WHO Classification of Tumours of Female Reproductive Organs. WHO Classification of Tumours. 4th ed. Vol. 6. Lyon: IARC.
   Google Scholar
• McConechy MK, Talhouk A, Leung S, Chiu D, Yang W, Senz J, et al. 2016. Endometrial carcinomas with POLE exonuclease domain mutations have a favorable prognosis. Clinical Cancer Research: Research 22:2865–2873.
   PubMed Web of Science ®Google Scholar
• Misirlioglu S, Guzel AB, Gulec UK, Gumurdulu D, Vardar MA. 2012. Prognostic factors determining recurrence in early-stage endometrial cancer. European Journal of Gynaecological Oncology 33:610–614.
   PubMed Web of Science ®Google Scholar
• Nout RA, Smit VT, Putter H, Jürgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, et al. 2010. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. The Lancet 375:816–823.
   PubMed Web of Science ®Google Scholar
• Randall ME, Filiaci VL, Muss H, Spirtos NM, Mannel RS, Fowler J, et al. 2006. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. Journal of Clinical Oncology 24:36–44.
   PubMed Web of Science ®Google Scholar
• Salvesen HB, Stefansson I, Kalvenes MB, Das S, Akslen LA. 2002. Loss of PTEN expression is associated with metastatic disease in patients with endometrial carcinoma. Cancer 94: 2185–2191.
   PubMed Web of Science ®Google Scholar
• Silverberg SG, Bolin MG, DeGiorgi LS. 1972. Adenoacanthoma and mixed adenosquamous carcinoma of the endometrium. A Clinicopathologic Study. Cancer 30:1307–1314.
   PubMed Web of Science ®Google Scholar
• Stelloo E, Nout RA, Osse EM, Jürgenliemk-Schulz IJ, Jobsen JJ, Lutgens LC, et al. 2016. Improved risk assessment by integrating molecular and clinicopathological factors in early-stage endometrial cancer-combined analysis of the PORTEC cohorts. Clinical Cancer Research: Research 22:4215–4224.
   PubMed Web of Science ®Google Scholar
• Sturgeon SR, Sherman ME, Kurman RJ, Berman ML, Mortel R, Twiggs LB, et al. 1998. Analysis of histopathological features of endometrioid uterine carcinomas and epidemiologic risk factors. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 7:231–235.
   PubMed Web of Science ®Google Scholar
• Tavassoli FA, Devilee P. 2003. Pathology and genetics of tumours of the breast and female genital organs. 3rd ed. Lyon: IARC (International Agency for Research on Cancer) Press.
   Google Scholar
• Uharček P. 2008. Prognostic factors in endometrial carcinoma. Journal of Obstetrics and Gynaecology Research 34:776–783.
   PubMed Web of Science ®Google Scholar
• Vermij L, Smit V, Nout R, Bosse T. 2020. Incorporation of molecular characteristics into endometrial cancer management. Histopathology 76:52–63.
   PubMed Web of Science ®Google Scholar
• Zaino R, Kurman R, Herbold D, Gliedman J, Bundy B, Voet R, Advani H. 1991. The significance of squamous differentiation in endometrial carcinoma. Cancer 68:2293–2302.
   PubMed Web of Science ®Google Scholar
• Zaino RJ, Kurman RJ. 1988. Squamous differentiation in carcinoma of the endometrium: a critical appraisal of adenoacanthoma and adenosquamous carcinoma. Seminars in Diagnostic Pathology 5:154–171.
   PubMed Web of Science ®Google Scholar